Intrinsic value of BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX)

Live fair value data for BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Downside: -6.0%

Margin of Safety: -6.4%

Current Price: $51.00

Valuation: Overvalued

Confidence: 4.0/10

Visual Bar

Market Price $51.00Intrinsic Value Locked

Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Is BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) undervalued or overvalued?

Based on the current model output, BlackRock Health Sciences Opportunities Portfolio Class K appears to be overvalued with a downside of 6.00%.

Fair value vs market price — BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX)

Unlock premium access to view the live fair value comparison against current market price for SHSKX.

Unlock Fair Value

Frequently Asked Questions - SHSKX

How is SHSKX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for SHSKX.

Is SHSKX undervalued or overvalued right now?

SHSKX is currently shown as overvalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for SHSKX: open their intrinsic value pages.

Explore Other Stocks

AAPL TSLA NVDA MSFT